Nuo Therapeutics, Inc. (AURX)

Equity Ratio

-58.46%

Quarterly · Period ending:

AURX logo

AURX Equity Ratio

Latest reported-58.46%
AURX Quarterly Equity Ratio (71.31% → -58.46%)
High-resolution chart · PNG

AURX equity ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. Equity Ratio — Quarterly
Period endingEquity Ratio
71.3076%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.